Global Diabetic Retinopathy Market Report 2022: Featuring Alimera Sciences, Pfizer, Genentech, Bayer, Lumenis & More – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Diabetic Retinopathy Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering. Diabetic retinopathy is among the leading causes of legal blindness among the working-age adults worldwide. Anticipated increase in prevalence of diabetes prevalence indicates that diabetic retinopathy will continue to the prevalence of vision